SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029137
Filing Date
2022-08-11
Accepted
2022-08-11 16:31:05
Documents
77
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rxdx-10q_20220630.htm   iXBRL 10-Q 2367914
2 EX-31.1 rxdx-ex311_6.htm EX-31.1 20879
3 EX-31.2 rxdx-ex312_9.htm EX-31.2 20607
4 EX-32.1 rxdx-ex321_7.htm EX-32.1 10271
5 EX-32.2 rxdx-ex322_8.htm EX-32.2 10051
  Complete submission text file 0001564590-22-029137.txt   9470965

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20220630.xsd EX-101.SCH 70289
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20220630_cal.xml EX-101.CAL 50559
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20220630_def.xml EX-101.DEF 253283
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20220630_lab.xml EX-101.LAB 536174
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20220630_pre.xml EX-101.PRE 432693
71 EXTRACTED XBRL INSTANCE DOCUMENT rxdx-10q_20220630_htm.xml XML 1736310
Mailing Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121 (858) 422-4300
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40187 | Film No.: 221156367
SIC: 2834 Pharmaceutical Preparations